Clinical trial
Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER)…
NCT00356018 · Orlando Health, Inc., Other · Completed
Key facts
| NCT number | NCT00356018 |
|---|---|
| Title | Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy: |
| Official title | Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy: A Randomized, Parallel, Prospectively-Controlled Outpatient Comparison |
| Lead sponsor | Orlando Health, Inc., Other |
| Collaborators | Abbott Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Epilepsy |
| Intervention type | Behavioral |
| Interventions | Compliance |
| Enrollment | 5 |
| Start date | Jul 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Jul 25, 2006 |
| Last update posted | Mar 4, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: